Cargando…
Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells
Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly cancers in the world due to late diagnosis and poor response to available treatments. It is important to identify treatment strategies that will increase the efficacy and reduce the toxicity of the currently used therapeutics. In this...
Autores principales: | Kutkowska, Justyna, Strzadala, Leon, Rapak, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214124/ https://www.ncbi.nlm.nih.gov/pubmed/30347681 http://dx.doi.org/10.3390/ijms19103234 |
Ejemplares similares
-
Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non‐small cell lung cancer cells
por: Kutkowska, Justyna, et al.
Publicado: (2017) -
The mitochondrial localization of RelB and NFATx in immature T cells
por: Stasik, Izabela, et al.
Publicado: (2008) -
Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells
por: Chiu, Ching-Feng, et al.
Publicado: (2021) -
Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors
por: Pawlak, Alicja, et al.
Publicado: (2016) -
Clonogenic Assay of Gastric Adenocarcinoma Stem Cells: Clonogenic Assay, Stomach Cancer
por: Kim, Hoon Kyo, et al.
Publicado: (1987)